Ticker LaunchLondon · AIM · IPO
Ondine Biomedical Inc.
Ondine Biomedical Inc. was admitted to AIM on Dec 6, 2021, raising $37.7M. Its market capitalization at admission was about $103.9M.
Ondine Biomedical Inc. is a Canadian life sciences company developing photodisinfection therapies, using antimicrobial photodynamic disinfection to prevent and treat drug-resistant infections, initially with devices for upper respiratory tract use.
- Type
- IPO
- Market
- AIM
- Admitted
- Dec 6, 2021
- Raised
- $37.7M
- Market cap at admission
- $103.9M
- Sector
- Biotech & pharma
- Country
- Canada
More on this listing for subscribers
- New money versus sale shares
- Free float
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- ThomasLloyd Energy Impact Trust plcMain Market · Dec 10, 2021
- 4GLOBAL plcAIM · Dec 7, 2021
- Windward Ltd.AIM · Dec 6, 2021
- Skillcast Group plcAIM · Dec 1, 2021
- Gelion plcAIM · Nov 30, 2021
- Hambro Perks Acquisition Company LimitedMain Market · Nov 30, 2021